Zopiclone: Overview and Clinical Use

Zopiclone is a non-benzodiazepine sedative-hypnotic drug mainly used to treat insomnia. Its mechanism of action is to enhance the inhibitory function of the central nervous system by selectively binding to gamma-aminobutyric acid (GABA) receptors, thereby shortening the time to fall asleep and extending the duration of sleep. This article will introduce the pharmacological properties, indications, usage and dosage, adverse reactions and manufacturers, focusing on its clinical value and safety.

Pharmacological properties and indications

Zopiclone has the characteristics of fast onset of action and short half-life. It usually produces a hypnotic effect 15-30 minutes after taking the drug, making it suitable for patients with insomnia who have difficulty falling asleep. Compared with benzodiazepines, they have lower addictive potential and lower next-day residual effects. It is mainly used clinically for the short-term treatment of insomnia in adults, especially when it is necessary to quickly improve sleep quality. It should be noted that long-term use may lead to tolerance, and it is generally recommended that the course of treatment does not exceed 4 weeks.

Usage, dosage and precautions

The recommended dose for adults is 7.5 mg, taken orally before going to bed. The elderly or those with liver dysfunction should reduce the dose to 3.75 mg. During medication, it is necessary to avoid drinking alcohol or combining it with other central depressants to prevent aggravation of sedation. It is contraindicated for special groups such as pregnant women, lactating women and patients with respiratory dysfunction. Some patients may experience mild adverse reactions such as bitter mouth and dizziness, which usually do not require special treatment.

Adverse reactions and drug interactions

Common adverse reactions include abnormal taste (about 20% of patients), drowsiness and headache, which mostly appear in the early stages of medication. Serious side effects such as memory impairment and abnormal behavior are rare. Concomitant use with CYP3A4 inhibitors (such as erythromycin) may enhance the efficacy, while concomitant use with inducers (such as rifampicin) may reduce the efficacy. During clinical use, patients should be regularly evaluated for sleep improvement and drug dependence.

Summary and production information

As a second-generation hypnotic, Zopiclone has achieved a good balance between efficacy and safety, but it must strictly follow the principle of short-term use. At present, many domestic pharmaceutical companies produce products in different dosage forms, and patients should use medications rationally under the guidance of doctors. The following table lists major manufacturers and product information:

Quote sources:
1. "China Guidelines for the Diagnosis and Treatment of Insomnia" (2017 Edition)
2. National Drug Administration drug database
3. Zopiclone drug instructions (approval date: 2021-03-15)